NCT00036309已完成3 期
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed the informed consent
- •Meet criteria for major depressive disorder without psychotic features.
- •Have a level of understanding sufficient to provide informed consent and to communicate with the investigator and site personnel.
- •Have had at least one other major depressive episode prior to the one being experienced at study entry.
- •You are reliable and agree to keep all appointments for clinic visits, tests and procedures required by the protocol.
排除标准
- •You have had treatment with a drug within the last 30 days that has not received regulatory approval at the time of study entry.
- •Any women who are pregnant or breast feeding.
- •If you have any serious medical illnesses other than major depressive disorder.
- •If you have previously participated in a clinical trial for duloxetine.
- •Any previous or current diagnosis of bipolar, schizophrenia, or other psychotic disorders.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderDepressive Disorder, MajorNCT00105989Eli Lilly and Company514
进行中（未招募）
不适用
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderMedDRA version: 8.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeMajor Depressive DisorderEUCTR2004-000167-95-DEEli Lilly and Company Limited500
进行中（未招募）
不适用
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderMajor Depressive DisorderEUCTR2004-000167-95-SEEli Lilly and Company Limited500
进行中（未招募）
不适用
Duloxetine versus Placebo in the Prevention of Recurrence in Major Depressive Disordermajor Depressive DisorderMedDRA version: 6.1Level: PTClassification code 10057840EUCTR2004-000167-95-ITELI LILLY
已完成
3 期
Duloxetine Versus Placebo in the Treatment of FMSFibromyalgiaNCT00233025Eli Lilly and Company320